Sponsor Dossier
Swedish Orphan Biovitrum
Sponsor Dossier for Swedish Orphan Biovitrum. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: DOPTELET
- Brand: EMPAVELI
- Brand: KINERET
- Brand: ZYNLONTA
- Device (sponsor): Mechanically-operated infusion pump set
- Device (sponsor): Mechanically-operated infusion pump
About
Swedish Orphan Biovitrum is an Australian Private Company with ABN 14 645 396 532, registered in NSW and currently active.
Portfolio
Swedish Orphan Biovitrum has four brands on the ARTG, with three indexable brands and three brands with Product Information on file. Three brands are PBS-listed, three have PBAC outcomes on record, and two have AusPARs on record. Notable brands include DOPTELET, EMPAVELI, KINERET, and ZYNLONTA.
Therapeutic focus —
Immunology: 2 brands — Oncology: 1 brand — Haematology: 1 brand
PBS footprint
Three brands in Swedish Orphan Biovitrum's portfolio are PBS-listed, with the latest PBS schedule date being 1 May 2026.
Regulatory activity
Swedish Orphan Biovitrum's most recent PBAC outcome is dated 1 May 2025, covering three brands with PBAC outcomes on record. The most recent AusPAR is dated 13 January 2023, with two brands holding AusPARs on record.